MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant

Bulletin Express07-06

MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s public-float requirements.

The company’s issued H-share capital closed the month at 141.80 million shares with a par value of RMB 1.00 each, unchanged from May 2026. No new shares were issued, cancelled, or repurchased, and MEDTIDE held no treasury shares during the period.

Total registered share capital stood at RMB 141.80 million, mirroring the issued share count. According to the filing, MEDTIDE met the Main Board’s minimum public-float requirement of 25% as at 30 June 2026.

The report recorded no activity under share option schemes, warrants, convertible instruments, or other equity-linked agreements, underscoring a static capital structure for the month.

The return was submitted by Joint Company Secretary Ng Tung Ching Raphael on 6 July 2026, fulfilling the company’s monthly disclosure obligations to Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108336724?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 17:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108336724","market":"hk","top_or_hot":-1,"title":"MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s public-float requirements.</p>\n<p>The company’s issued H-share capital closed the month at 141.80 million shares with a par value of RMB 1.00 each, unchanged from May 2026. No new shares were issued, cancelled, or repurchased, and MEDTIDE held no treasury shares during the period.</p>\n<p>Total registered share capital stood at RMB 141.80 million, mirroring the issued share count. According to the filing, MEDTIDE met the Main Board’s minimum public-float requirement of 25% as at 30 June 2026.</p>\n<p>The report recorded no activity under share option schemes, warrants, convertible instruments, or other equity-linked agreements, underscoring a static capital structure for the month.</p>\n<p>The return was submitted by Joint Company Secretary Ng Tung Ching Raphael on 6 July 2026, fulfilling the company’s monthly disclosure obligations to Hong Kong Exchanges and Clearing Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDTIDE Reports No Change in Share Capital for June 2026; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-06 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s public-float requirements.</p>\n<p>The company’s issued H-share capital closed the month at 141.80 million shares with a par value of RMB 1.00 each, unchanged from May 2026. No new shares were issued, cancelled, or repurchased, and MEDTIDE held no treasury shares during the period.</p>\n<p>Total registered share capital stood at RMB 141.80 million, mirroring the issued share count. According to the filing, MEDTIDE met the Main Board’s minimum public-float requirement of 25% as at 30 June 2026.</p>\n<p>The report recorded no activity under share option schemes, warrants, convertible instruments, or other equity-linked agreements, underscoring a static capital structure for the month.</p>\n<p>The return was submitted by Joint Company Secretary Ng Tung Ching Raphael on 6 July 2026, fulfilling the company’s monthly disclosure obligations to Hong Kong Exchanges and Clearing Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03880","symbol_name":"泰德医药","start_time":0,"source_url":"","article_id":"1108336724","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108336724","pubTimestamp":1783329818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03880":"泰德医药"},"translate_title":"MEDTIDE报告2026年6月股本没有变化；公众持股量保持合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03880":1},"content_text":"MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s public-float requirements.\nThe company’s issued H-share capital closed the month at 141.80 million shares with a par value of RMB 1.00 each, unchanged from May 2026. No new shares were issued, cancelled, or repurchased, and MEDTIDE held no treasury shares during the period.\nTotal registered share capital stood at RMB 141.80 million, mirroring the issued share count. According to the filing, MEDTIDE met the Main Board’s minimum public-float requirement of 25% as at 30 June 2026.\nThe report recorded no activity under share option schemes, warrants, convertible instruments, or other equity-linked agreements, underscoring a static capital structure for the month.\nThe return was submitted by Joint Company Secretary Ng Tung Ching Raphael on 6 July 2026, fulfilling the company’s monthly disclosure obligations to Hong Kong Exchanges and Clearing Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108336724","isCrawlerRequest":true}